Triphase Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.65 M
as on 18-12-2024
- Paid Up Capital ₹ 1.25 M
as on 18-12-2024
- Company Age 18 Year, 6 Months
- Last Filing with ROC 31 Mar 2022
- Revenue 233.15%
(FY 2022)
- Profit -50.91%
(FY 2022)
- Ebitda -46.19%
(FY 2022)
- Net Worth -188.32%
(FY 2022)
- Total Assets -18.32%
(FY 2022)
About Triphase Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.65 M and a paid-up capital of Rs 1.25 M, as per Ministry of Corporate Affairs (MCA) records.
Aditya Desiraju and Perumal Manoharan serve as directors at the Company.
- CIN/LLPIN
U73100KA2006PTC039605
- Company No.
039605
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Jun 2006
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Mysore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Triphase Pharmaceuticals Private Limited offer?
Triphase Pharmaceuticals Private Limited offers a wide range of products and services, including Flavours & Aromatics, Dough Conditioners, Digestive System Drugs & Medicines, Digestive Drugs, Data Entry & Data Processing Service, Data Conversion Services, Herbal Extracts, Animal Feed Supplement, Aqua Feed Supplement.
Who are the key members and board of directors at Triphase Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aditya Desiraju  | Additional Director | 02-Mar-2023 | Current |
Perumal Manoharan  | Additional Director | 02-Mar-2023 | Current |
Financial Performance of Triphase Pharmaceuticals.
Triphase Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 233.15% increase. The company also saw a substantial fall in profitability, with a 50.91% decrease in profit. The company's net worth observed a substantial decline by a decrease of 188.32%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Triphase Pharmaceuticals?
In 2022, Triphase Pharmaceuticals had a promoter holding of 99.64% and a public holding of 0.36%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
_PRIVATE_LIMITED.webp)
Synbiopro Nutraceutix (Opc) Private LimitedActive 3 years 10 monthsAditya Desiraju is a mutual person
Mayuresh Business Consultancy Private LimitedActive 2 years 2 monthsPerumal Manoharan is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Triphase Pharmaceuticals?
Triphase Pharmaceuticals has a workforce of 12 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Triphase Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Triphase Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
